Clinical Trials Browser

Phase 2 × Congenital Abnormalities × bryostatin 1 × Clear all

NCT00017342 2010-03-01

Bryostatin 1 and Cytarabine in Treating Patients With Relapsed Acute Myelogenous Leukemia

Phase 2 Completed

Other hematologic neoplasm

Congenital Abnormalities, Leukemia, Leukemia, Myeloid, Acute